Journal of dermatological scienceHumansPsoriasisFemaleMaleAntibodies
Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT study.
James G Krueger, Akimichi Morita, Mona Uchida-Yamada, Chiharu Tateishi, Eisaku Ogawa, Koji Masuda, Yukie Yamaguchi, Hong Beom Hur, Sandra Garcet, Naomi Shishido-Takahashi, Yasumasa Kanai
Published: 202510.1016/j.jdermsci.2025.09.005
Abstract
BACKGROUND: Brodalumab, an anti-interleukin-17 receptor A antibody, is effective in psoriasis via action on the IL-17 pathway. OBJECTIVE: This analysis of an exploratory intervention study (ESPRIT) in Japanese patients with moderate to severe plaque…
Preview only. Read the full abstract at the source